Infectious Disorders: PNA, TB, Bronchi, Bronchio, Epiglottitis, Croup Flashcards
Most common cause bacterial CAP worldwide
Streptococcus pneumonia
Rate and season of CAP
5-6 cases / 1000 ppl (or ~2 million / year in US)
More common in winter
Men / Black ppl
Elderly
Technical differentiation between CAP and hospital-facility acquired pneumonia
A person w CAP has not been hospitalized or in long term care facility for at least 14 days
Clinical features CAP
1-10 day history increasing cough
Purulent sputum
Pleuritic chest pain
SOB
Tachycardia
Fever
Sweats
Rigors
3 microorganisms that cause 85% of CAP
Streptococcus pneumonia
Moraxella catarrhalis
Haemophilus influenza
Physical exam findings CAP
Lung Exam:
Rales/Crackles
Increased tactile fremitus (consolidation)
Bronchial breath sounds over an area of consolidation
“Dense consolidation of the lung parenchyma, as can occur with pneumonia, results in the transmission of large airway noises (i.e. those normally heard on auscultation over the trachea… known as tubular or bronchial breath sounds) to the periphery. “
“Altered breath sounds”
What does “dullness to percussion” and/or decreased tactile fremitus indicate on physical exam?
Pleural effusion
What physical exam findings indicate lung consolidation
Increased tactile fremitus
“special” tests (bronchophony, ego phony, whisper)
Bronchial breath sounds - Dense consolidation of the lung parenchyma, as can occur with pneumonia, results in the transmission of large airway noises (i.e. those normally heard on auscultation over the trachea… known as tubular or bronchial breath sounds) to the periphery.
Consolidation vs effusion?
Consolidation occurs when the normally air filled lung parenchyma becomes engorged with fluid or tissue.
In the presence of consolation, fremitus becomes more pronounced.
Fluid, known as a pleural effusion, can collect in the potential space that exists between the lung and the chest wall, displacing the lung upwards. Fremitus over an effusion will be decreased.
Most basic CAP workup
H&P
CXR
Pulse Ox
Additional CAP diagnostics
Routine Lab: CBC, BMP, LFT
Sputum culture / gram stain
Blood culture
ABG (hospital setting)
CXR findings PNA
Lobar or segmental infiltrates
Air bronchograms*
*refers to the phenomenon of air-filled bronchi (dark) being made visible by the opacification of surrounding alveoli (grey/white). It is almost always caused by a pathologic airspace/alveolar process, in which something other than air fills the alveoli.
Pleural effusions
Treatment for pleural effusion?
Thoracentesis in hospital setting
CURB 65 scoring to determine outpatient / inpatient treatment of CAP
C - Confusion
U - Blood Urea Nitrogen 20mg/L or up
R - Respiratory rate 30/min or up
B - BP < 90 / < or = 60 (89/60 or below)
65 - Age 65 or up
Scores: 0-1 = outpatient 2 = closely observed outpatient or inpatient observe, depending on risk factors of patient 3 = inpatient 4 or 5 = inpatient / ICU
Other considerations for Hospitalization: HI 5
- Hemodynamic instability
- Involvement of more than one lobe
- 50 yrs + with comorbidities
Outpatient, uncomplicated CAP treatment (previously healthy, no use of antibiotics in past 3 months)
7-10 days of:
1st line: Macrolide (clarithromycin, azithromycin)
or
2nd/3rd line: fluoroquinalone
Outpatient CAP treatment for patient with underlying chronic disease or use of antimicrobials in past 3 months
7-10 days of:
1st line: Fluoroquinolone (Moxi 400mg, Levo 750mg, Gemi)
or
Alt 1st line: Macrolide (clarithro / azithro) + beta lactam (amoxicillin / augmentin / ceftriaxone / cefotaxime)
Inpatient treatment CAP, non ICU
Consider coverage of S. pneumo AND Legionella
1st line: Fluoroquinolone (Moxi 400mg, Levo 750mg, Gemi)
Alt 1st line: Macrolide (azithro / clarithro) + beta lactam (ceftriaxone / cefotaxime)
Inpatient treatment CAP in ICU
Beta Lactam (Cefotazime, Ceftriaxone, Ampicillin-sulbactam)
+
Fluroquinolone (Moxi 400mg, Levo750mg)
or (2nd line) Azithromycin
Inpatient pen-allergic ICU CAP treatment
Fluoroquinolone + Aztreonam (monobactam)
Treatment if pseudomonas is suspected agent:
Fluoroquinolone (Cipro / Levo)
+
Beta Lactam for pneumo/pseudo (Piperacillin / Cefepime / Imipenem / Miropenem
Vaccine recommended for all patients 65 and older
PPSV23 AND PCV13
Atypical CAP most commonly found in what populations
young adults, living in close proximity
- college dorms
- military
- boarding schools
Most common causes of Atypical CAP
1 - Mycoplasma pneumoniae
Chlamydia pneumoniae
Legionella sp. (air conditioning, humidifiers)
Moraxella sp.
Influenza A / B
Clinical features Atypical CAP
Low grade fever
Persistent dry cough
Constitutional: malaise, myalgia, headache
“smouldering” illness
Distinctive Mycoplasma findings
“Bullous myringitis” - reddened tympanic membrane
Vesicular rash
Distinctive Legionella findings
Systemic illness: diarrhea, hyponatremia
Distinctive Chlamydia findings
Longer prodrome
Sore throat, hoarseness
Atypical CAP Diagnostic Workup
H&P
Dry cough that is not resolving
CXR usually confirms infiltrates
Routine labs usually not too bad (WBC, BMP, sputum)
Treatment usually based on clinical diagnosis alone
Atypical CAP Treatment
** No Beta Lactams **
Choose Macrolide, Fluoroquinalone, Tetracycline
Azithro or Clarithromycin or Doxycycline (Mycoplasma, Legionella)
Tetracycline if Chlamydia suspected
Hospital acquired pneumonia (HAP) and VAP, distinctions
Clinical infection more than 48 hours after hospital admission
ICU patients on ventilators at highest risk (VAP) - developed 47-72 hours after endotrachial intubation
Patients at risk for HCAP (Healthcare-associated pneumonia)
Within past 30 days: IV therapy Chemotherapy Wound care Dialysis
Within 90 days:
Acute care hospitalization for 2+ days
Causative organisms for HAPs
S. Aureus
and Gram Neg Bacilli:
- Pseudomonas (ICU)
- Klebsiella
- E. coli
- Enterobacter
Best Diagnostics for HAPs
SPUTUM CULTURE
Blood Cultures
Bronchoalveolar lavage - if can’t obtain sputum culture
Early onset (<5 days) HAP treatment, no MDR risk factors
Based on Culture and Sensitivity Results
Cetriaxone
Levo
Ampicillin-sulbactam
x8 days
Late onset (>5 days) treatment, +MDR risk, HCAP
Based on Culture and Sensitivity Results
Cipro or Levo
Cefepime
Ceftazidime
Imipenem
Miropenem
Piperacillin
Vancomycin
Linezolid
Indication of a sputum culture / gram stain with ** mixed flora **
Aspiration pneumonia
Most common cause of bacterial pneumonia in HIV patients
Streptococcus pneumo
Most common “opportunistic infection” in HIV patients
Pneumocystis jiroveci
Treatment of choice for pneumonia in HIV patients
Bactrim (trimethroprim - sulfamethoxazole)
**prophylaxis indicated in all patients w CD4 counts < 200 **
Of the very uncommon fungal pneumonia, which is most common causative agent
Histoplasma capsulatum
CXR indicative of Histoplasmosis
GRANULOMAS
**confirm with bronchoalveolar lavage or biopsy **
or serologic testing
Tx Histoplamosis
Itraonazole (mild)
Amphotercin B (severe)
Primary TB
vs
Progressive Primary TB
vs
Latent TB
Primary TB: 10% of persons infected w TB, immune system able to prevent progression. Form granulomas
Progressive primary TB: 5% ppl fail to contain primary infection and progress to active TB
Latent TB: 95% of ppl contain bacterium without becoming symptomatic. Not infectious, asymptomatic.
Clinical features TB
Dry cough, progressing to productive cough - with or without hemoptysis »_space; 3 weeks +
** Drenching night sweats, weight loss, Posttussive rales**
Primary TB Radiography
Homogenous infiltrates
“Segmental atelectasis” (collapse of one or several segments of lung)
Lung Cavitations
Hilar/Paratracheal lymph swelling
Reactivation TB Radiography
Apical fibrocavitary infiltrates
Radiography findings in healed primary infection
Ghon complexes (calcified primary focus)
Ranke complexes (Ghon + calcified hilar lymph node)
Tuberculin Skin Test (TST) PPD reported according to
DIAMETER of induration - NOT erythema
Identifies but does not differentiate between active / latent!
Definitive diagnosis of TB
ID of M. tuberculosis via sputum cultures or DNA/RNA amplification
Histologic hallmark of TB
Biopsy revealing caseating granulomas (aka, necrotizing granulomas)
LTBI Treatment
Isoniazid (INH) for 9 months
or Rifampin (RIF) for 4 months
or RIF and Pyrazinamide (PZA) for 2 months - if contact w resistant strains
Active TB Tx
Isoniazid (INH) + RIF + PZA + Ethambutol (EMB) for 2 months
+
Additional 4 months mutlidrug treatment based on culture sensitivity results
Length of multi drug treatment of HIV patients w TB?
1 year
Prophylaxis TB treatment?
INH for 6-12 months
Inflammation of airways, characterized by cough
Bronchitis
> 90% cases of acute bronchitis caused by
VIRUSES (including RSV)
** bacterial causes considered in patients w chronic lung diseases (S. pneumo, H. influenza, M. catarrhalis)
Is sputum color predictive of bacterial involvement for acute bronchitis?
NO
Diagnostic studies for acute bronchitis
Generally none, unless need to differentiate bronchitis from pneumonia
CXR negative in bronchitis
Treatment acute bronchitis
Supportive - unless exacerbation of chronic bronchitis»
> > 1st line: 2nd gen cephalosporin
2nd line: or 2nd gen macrolide or Bactrim
When are antibiotics indicated for acute bronchitis?
Elderly
Underlying cardiopulmonary diseases and cough for +7-10 days
Any immunocompromised patient
Inflammation of the bronchioles (airways <2mm diameter)
Primarily illness of young children and infants
Acute bronchiolitis
Most common cause of Acute Bronchiolitis, and others
RSV
Others:
Parainfluenza
Adenovirus
Rhinovirus
Clinical features of respiratory distress in pediatrics w acute bronchiolitis
Nasal flaring
Tachypnea
Retractions
Diagnostic studies - acute bronchiolitis / RSV
CBC - usually normal
CXR - normal but can show bronchial thickening / air trapping
Nasal washing for RSV culture ** often done for infants **
Treatment / management of RSV
If present, consider hospitalization, esp premature infants
+ RIBAVARIN
Supportive measures: Antipyretics Nebulized albuterol IV fluids humidified O2 Chest physiotherapy?
HIB vaccine has decreased incidence of this in children, but can still be found in unimmunized adults or caused by Strep A
Acute epiglottitis
Sudden onset high fever Severe Dysphagia Drooling Muffled voice Posture compensation Respiratory Distress
Acute epiglottitis
Management of Acute Epiglottitis
Secure Airway
Broad spectrum 2nd-3rd gen cephalosporins
(Cefotaxime, Ceftriaxone)
Dexaeathasone to reduce inflammation
Harsh, barking, cough
Inspiratory stridor
Aphonia
infection with Parainflueza, RSV, other viruses
Croup
Diagnostic studies for Croup
PA (postanterior) Neck Film:
Shows Steeple Sign (subglottic narrowing)
this differentiates croup from epiglottitis
Management for Croup
Usually only supportive
** Hydration is very important**
Corticosteroids
Humidified O2
Nebulized epinephrine